MERCURYLABPharmaceuticals
Mercury Labs — PE Ratio & Valuation Analysis
₹860.00
+0.00%
Current P/E20.79xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E19.0x9.4% above avg
✅
34.6% Discount to Industry
MERCURYLAB P/E 20.79x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2024 | ₹47.12 | ₹896 | 19x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Mercury Labs Valuation
Mercury Labs (MERCURYLAB) currently trades at 20.79x earnings. The Pharmaceuticals sector average PE is 31.77x. MERCURYLAB is trading at a discount to peers — may indicate relative value. Historically, MERCURYLAB has traded at an average PE of 19.0x — it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
5.94%
Dividend Yield
0.41%
More on Mercury Labs
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.